FDA Homepage
News & Events
- April 22, 2019 - Statement from Peter Marks, M.D., Ph.D., director of FDA’s Center for Biologics Evaluation and Research, on FDA’s continued confidence in the safety and effectiveness of the measles, mumps, and rubella (MMR) vaccine
- April 19, 2019 - FDA permits marketing of first medical device for treatment of ADHD
- April 19, 2019 - FDA approves first generic naloxone nasal spray to treat opioid overdose
Newsroom
Recent Consumer Updates
Browse by Audience
-
For Consumers
Updates and information for staying safe and healthy -
For Patients
Learn about other treatments, drug/device approvals, public meetings and more -
For Health Professionals
Medical product safety information, adverse event/problem reporting and more -
For Scientists & Researchers
NCTR, pediatrics, clinical trials, Critical Path Initiative, foods and veterinary medicine research, and more -
For Industry
Guidance, registration and listing, pay user fees, import programs and more
FDA Voices:
Perspectives from FDA Experts
-
April 17, 2019
FDA’s Efforts to Advance the Development of Biologics
Page Last Updated: 04/22/2019
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English